184 related articles for article (PubMed ID: 10464328)
1. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.
Hellmark T; Burkhardt H; Wieslander J
J Biol Chem; 1999 Sep; 274(36):25862-8. PubMed ID: 10464328
[TBL] [Abstract][Full Text] [Related]
2. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
Kalluri R; Sun MJ; Hudson BG; Neilson EG
J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
[TBL] [Abstract][Full Text] [Related]
3. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
MacDonald BA; Sund M; Grant MA; Pfaff KL; Holthaus K; Zon LI; Kalluri R
Blood; 2006 Mar; 107(5):1908-15. PubMed ID: 16254142
[TBL] [Abstract][Full Text] [Related]
4. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
Hellmark T; Segelmark M; Unger C; Burkhardt H; Saus J; Wieslander J
Kidney Int; 1999 Mar; 55(3):936-44. PubMed ID: 10027930
[TBL] [Abstract][Full Text] [Related]
5. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.
Borza DB; Netzer KO; Leinonen A; Todd P; Cervera J; Saus J; Hudson BG
J Biol Chem; 2000 Feb; 275(8):6030-7. PubMed ID: 10681598
[TBL] [Abstract][Full Text] [Related]
6. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
7. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.
Netzer KO; Leinonen A; Boutaud A; Borza DB; Todd P; Gunwar S; Langeveld JP; Hudson BG
J Biol Chem; 1999 Apr; 274(16):11267-74. PubMed ID: 10196215
[TBL] [Abstract][Full Text] [Related]
8. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope.
David M; Borza DB; Leinonen A; Belmont JM; Hudson BG
J Biol Chem; 2001 Mar; 276(9):6370-7. PubMed ID: 11098057
[TBL] [Abstract][Full Text] [Related]
10. Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.
Hellmark T; Chen L; Ohlsson S; Wieslander J; Bolton WK
J Biol Chem; 2003 Nov; 278(47):46516-22. PubMed ID: 12970356
[TBL] [Abstract][Full Text] [Related]
11. Molecular mapping of the Goodpasture's epitope for glomerulonephritis.
Bolton WK; Chen L; Hellmark T; Fox J; Wieslander J
Trans Am Clin Climatol Assoc; 2005; 116():229-36; discussion 237-8. PubMed ID: 16555617
[TBL] [Abstract][Full Text] [Related]
12. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats.
Chen L; Hellmark T; Wieslander J; Bolton WK
Kidney Int; 2003 Dec; 64(6):2108-20. PubMed ID: 14633133
[TBL] [Abstract][Full Text] [Related]
13. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen.
Kalluri R; Gunwar S; Reeders ST; Morrison KC; Mariyama M; Ebner KE; Noelken ME; Hudson BG
J Biol Chem; 1991 Dec; 266(35):24018-24. PubMed ID: 1721062
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
16. Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.
Reynolds J; Haxby J; Juggapah JK; Evans DJ; Pusey CD
Clin Exp Immunol; 2009 Feb; 155(2):311-9. PubMed ID: 19040602
[TBL] [Abstract][Full Text] [Related]
17. Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants.
Meyers KE; Kinniry PA; Kalluri R; Neilson EG; Madaio MP
Kidney Int; 1998 Feb; 53(2):402-7. PubMed ID: 9461099
[TBL] [Abstract][Full Text] [Related]
18. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen.
Neilson EG; Kalluri R; Sun MJ; Gunwar S; Danoff T; Mariyama M; Myers JC; Reeders ST; Hudson BG
J Biol Chem; 1993 Apr; 268(12):8402-5. PubMed ID: 8473281
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
Hellmark T; Brunmark C; Trojnar J; Wieslander J
Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
[TBL] [Abstract][Full Text] [Related]
20. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
